Invention Grant
- Patent Title: CRISPR-Cas complex
-
Application No.: US17554465Application Date: 2021-12-17
-
Publication No.: US11760985B2Publication Date: 2023-09-19
- Inventor: John Van Der Oost
- Applicant: Wageningen Universiteit
- Applicant Address: NL Wageningen
- Assignee: WAGENINGEN UNIVERSITEIT
- Current Assignee: WAGENINGEN UNIVERSITEIT
- Current Assignee Address: NL Wageningen
- Agency: FOLEY & LARDNER LLP
- Priority: GB 06509 2015.04.16
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/11

Abstract:
The invention related to the field of genetic engineering tools, methods and techniques for gene or genome editing. Specifically, the invention concerns isolated polypeptides having nuclease activity, host cells and expression vectors comprising nucleic acids encoding said polypeptides as well as methods of cleaving and editing target nucleic acids in a sequence-specific matter. The poly peptides, nucleic acids, expression vectors, host cells and methods of the present invention have application in many fields of biotechnology, including, for example, synthetic biology and gene therapy.
Public/Granted literature
- US20220213454A1 NUCLEASE-MEDIATED GENOME EDITING Public/Granted day:2022-07-07
Information query